Different effectiveness of Helicobacter pylori lipopolysaccharides with or without LewisXY determinants in stimulating the secretion of proinflammatory cytokines IL-8 and TNF-α by peripheral blood mononuclear leukocytes

Przeglad Gastroenterologiczny

Volumn 6, Issue 6, 2011, Pages 401-408

  Rudnicka, Karolina ^a   Grȩbowska, Aneta ^a   Moran, Anthony P ^b   Matusiak, Agnieszka ^a   Walencka, Maria ^a   Miszczyk, Eliza ^a   Ba̧k Romaniszyn, Leokadia ^c   Czkwianianc, Elzbieta ^c   Płaneta Małecka, Izabela ^c   Rudnicka, Wiesława ^a   Chmiela, Magdalena ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Helicobacter pylori; Interleukin 8; Lipopolysaccharides; Tumour necrosis factor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HELICOBACTER PYLORI LIPOPOLYSACCHARIDE; INTERLEUKIN 8; LIPOPOLYSACCHARIDE BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LEUKOCYTE; LYMPHOCYTE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; STIMULUS RESPONSE; SUPERNATANT;

EID: 83055185615     PISSN: 18955770     EISSN: 18974317     Source Type: Journal    
DOI: 10.5114/pg.2011.25996     Document Type: Article

References (30)

1. Warren JM, Marshall BJ. Unidentified curved bacilli on the gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-5.
2. Pflock M, Kennard S, Finsterer N, et al. Acid-responsive gene regulation in the human pathogen Helicobacter pylori. J Biotechnol 2006; 126: 52-60. (Pubitemid 44402773)
3. Mahdavi J, Sonden B, Hurtig M, et al. Helicobacter pylori SabA adhesion in persistent infection and chronic inflammation. Science 2002; 297: 573-8. (Pubitemid 34815336)
4. Wu AM, Crabtree JE, Bernstein L, et al. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 2003; 103: 815-21. (Pubitemid 36110240)
5. El-Omar EM, Carrington M, Chow W, et al. Interleukin 1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402. (Pubitemid 30164342)
6. Kunstmann E, Epplen C, Elitok E, et al. Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis 1999; 20: 1756-61. (Pubitemid 29320470)
7. Sakagami T, Dixon M, Orourke J, et at. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 1996; 39: 639-48.
8. Gianchetti P, Vaira D, Campieri M, et al. Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori positive dyspeptic patients. Am J Gastroenterol 1994; 89: 883-7. (Pubitemid 24165914)
9. Noach L, Bosma NB, Jansen J, et al. Mucosal tumor necrosis factor-alpha, interleukin-1beta and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29: 425-9. (Pubitemid 24144511)
10. Portnoy DA. Manipulation of innate immunity by bacterial pathogens. Curr Opin Immunol 2005; 17: 25-8. (Pubitemid 40094009)
11. Miller SI, Ernst RK, Bader MW, et al. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005; 3: 36-46. (Pubitemid 40028467)
12. Monteiro MA, Appelmelk BJ, Rasko DA, et al. Lipopolysaccharide structures of Helicobacter pylori genomic strains 26695 and J99, mouse model H. pylori Sydney strain, H. pylori P466 carrying sialyl LewisX and H. pylori UA915 expressing LewisB. Classification of H. pylori lipopolysaccharides into glycotype families. Eur J Biochem 2000; 267: 305-20. (Pubitemid 30072890)
13. Khamri W, Moran AP, Worku ML, et al. Variations in Helicobacter pylori lipopolysaccharide to evade the innate immune component surfactant protein D. Infect Immun 2005; 73: 7677-86. (Pubitemid 41587674)
14. Moran AP, Knirel YA, Senchenkova SN, et al. Phenotypic variation in molecular mimicry between Helicobacter pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms. Acid-induced phase variation in Lewis (x) and Lewis (y) expression by H. pylori lipopolysaccharides. J Biol Chem 2002; 277: 5785-95. (Pubitemid 34968356)
15. Skoglund A, Backhed HK, Nilsson CH, et al. A changing gastric environment leads to adaptation of lipopolysaccharide variants in Helicobacter pylori populations during colonization. PLoS 2009; 4: e5885.
16. Munzenmaier A, Lange C, Glocher E, et al. A secreted, shed product of Helicobacter pylori activates transcription factor nuclear factor-kappaB. J Immunol 1997; 159: 6140-7. (Pubitemid 127471553)
17. Bergman MP, Engering A, Amits HH, et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 2004; 200: 979-90. (Pubitemid 39431123)
18. Bielański W, Konturek SJ. New approach to 13C urea breath test capsule-based modification with low dose of 13C urea in the diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 1996; 47: 545-53. (Pubitemid 26288782)
19. Rechciński T, Chmiela M, Małecka-Panas E, et al. Serological indicators of Helicobacter pylori infections in adult dyspeptic patients and healthy blood donors. Microbiol Immunol 1997; 41: 387-93. (Pubitemid 27224919)
20. Rieder G, Hatz RA, Moran AP, et al. Role of adherence in Interleukin-8 induction in Helicobacter pylori associated gastritis. Infect Immun 1997; 65: 3622-30. (Pubitemid 27398116)
21. Shimuyama T, Fukuda S, Liu Q, et al. Helicobacter pylori water soluble surface proteins prime human neutrophils for enhanced production of reactive oxygen species and stimulate chemokine production. J Clin Pathol 2003; 56: 348-51. (Pubitemid 36566819)
22. Ando T, Goto Y, Ishigurob K, et al. The interaction of host genetic factors and Helicobacter pylori infection. Inflammopharmacology 2007; 15: 10-4. (Pubitemid 46333879)
23. Blaser M, Berg D. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107: 767-73. (Pubitemid 32274024)
24. Israel DA, Salama N, Arnold CN, et al. Helicobacter pylori genetic diversity within the gastric niche of single human host. J Clin Invest 2001; 107: 611-20.
25. Blaser MJ. Helicobacter pylori balance and imbalance. J Gastroenterol Hepatol 1998; 10 (Suppl. 1): S15-8.
26. Grebowska A, Moran AP, Matusiak A, et al. Anti-phagocytic activity of Helicobacter pylori lipopolysaccharide (LPS) - possible modulation of the innate immune response to these bacteria. Pol J Microbiol 2008; 57: 195-92.
27. Moran AP, Aspinall GO. Unique structural and biologic features of Helicobacter pylori lipopolysaccharides. Prog Clin Biol Res 1998; 397: 37-49.
28. Lepper PM, Triantafilou M, Schumann C, et al. Lipopolysaccharides from Helicobacter pylori can act as antagonists for Tolllike receptor 4. Cell Microbiol 2005; 7: 519-28. (Pubitemid 40439451)
29. Grebowska A, Rechcinski T, Moran A, et al. Increased levels of immunoglobulin and non-immunoglobulin markers of host response to H. pylori LPS in the patients with coronary artery disease (CAD). Current Trends in Immunol 2006; 7: 85-96. (Pubitemid 47292656)
30. Cross ML. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 2002; 34: 245-53. (Pubitemid 35351374)